HomeNXEN • OTCMKTS
add
Nexien Biopharma Inc
Previous close
$0.0070
Year range
$0.0041 - $0.050
Market cap
297.24K USD
Avg Volume
4.69K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.03K | 78.83% |
Net income | -39.47K | -60.99% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.31K | -50.13% |
Total assets | 1.31K | -50.13% |
Total liabilities | 424.00K | 33.83% |
Total equity | -422.69K | — |
Shares outstanding | 70.77M | — |
Price to book | -0.70 | — |
Return on assets | -1,919.72% | — |
Return on capital | 88.90% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -39.47K | -60.99% |
Cash from operations | -28.65K | -85.48% |
Cash from investing | — | — |
Cash from financing | 25.00K | — |
Net change in cash | -3.65K | 76.39% |
Free cash flow | -15.78K | -113.90% |
About
Founded
1952
Website
